RECRUITING

Cognitive Behavioral and Faith Fellowship to Improve Thy Health

Talk to us

Conditions

Depressionfaith-based intervention

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators will examine the efficacy of a faith-based depression intervention, in reducing symptoms of depression among African American adults in Wisconsin. Twelve church groups, each with 10 people (N=120) will be invited to participate. This intervention will be the first evidence-based, faith-based intervention designed for African Americans if validated.

Official Title

Cognitive Behavioral and Faith Fellowship to Improve Thy Health (CB-FAITH) - a Feasibility and Acceptability Study

Quick Facts

Study Start:2024-10-08
Study Completion:2026-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06292637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * self-identify as an African American man or woman
  2. * are ages 18 and older
  3. * have symptoms of major depressive disorder, as evidenced by score of 10 and higher from the Patient Health Questionnaire-9 (PHQ-9).
  1. * major psychotic illnesses, such as schizophrenia;
  2. * current participation in psychotherapy
  3. * current suicidal ideations (trained staff will conduct a suicide risk assessment and facilitate referral for appropriate care).
  4. * Medication stabilization. Eligible participants who report recent changes to their psychiatric medications (i.e., initiation of a new medication, change in dose or type of medication) will delay their study enrollment for a stabilization period of 4 weeks. Baseline data collection will be re-administered
  5. * alcohol or drug dependence - those with alcohol or other drug dependence who have been clean and sober for 3 months will not be excluded

Contacts and Locations

Study Contact

Earlise Ward, PhD
CONTACT
608/263-0745
ecward@wisc.edu

Principal Investigator

Earlise Ward, PhD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

Second Baptist Church
Madison, Wisconsin, 53711-3800
United States
The Board of Regents of the UW System
Madison, Wisconsin, 53715-1218
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Earlise Ward, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-08
Study Completion Date2026-09

Study Record Updates

Study Start Date2024-10-08
Study Completion Date2026-09

Terms related to this study

Keywords Provided by Researchers

  • faith-based intervention

Additional Relevant MeSH Terms

  • Depression